What Cormica does

Cormica is a privately held contract research organization (CRO) headquartered in London that provides GMP-, GLP-, and ISO 17025-accredited testing services to pharmaceutical, medical device, and combination product manufacturers. Operating through wholly owned laboratory subsidiaries in the United Kingdom (Wickham Micro, Medical Engineering Technologies UK, Cormica Bradford), the European Union (Zwisler Laboratorium in Germany), and the United States (Focus Laboratories and TPM Labs, the latter acquired in May 2024), Cormica offers an integrated service portfolio spanning analytical chemistry, microbiology, sterility and endotoxin testing, physical and mechanical testing, packaging validation, and biocompatibility (ISO 10993) testing and consultancy. The company is backed by private equity sponsor Limerston Capital and reports a heritage of more than 60 years of supporting device and pharmaceutical programmes.

The underlying technology base consists of advanced analytical instrumentation including Agilent and Thermo HPLC and uHPLC systems with LC-MS/MS, PerkinElmer and Thermo GC-FID/GC-MS/MS, Agilent ICP-MS and Thermo ICP-OES, Bruker XRPD, DSC/TGA, BET, DVS, SEM, and Malvern particle sizing platforms, all operated under UKAS, MHRA, FDA, and MDR-compliant quality systems. Service offerings are structured around horizontal customer segments (pharmaceutical manufacturers, medical device manufacturers, combination product manufacturers, with niche exposure to advanced wound care and agrochemicals), and span the full product lifecycle from pre-formulation and method development through QC batch release, ICH stability studies, extractables and leachables, packaging validation, and post-market surveillance.

Cormica generates revenue through project-based, custom-quoted laboratory testing and scientific consultancy contracts billed on a pay-as-you-go basis, with go-to-market executed via direct enterprise field sales, technical webinars, trade show participation, and industry conference engagement targeting quality, regulatory, and R&D decision-makers at manufacturing companies. Pricing is not publicly disclosed and is determined per project by scope, sample count, testing complexity, turnaround, and applicable regulatory standards. Distribution is direct-only, with no resellers or third-party channels.

Name

Cormica

Legal name

Cormica Ltd

Website

https://cormica.com

Company type

Private

Founded year

1960

Operating status

Operating

Short description

Cormica is a PE-backed, GMP/GLP/ISO 17025-accredited contract research organization providing analytical chemistry, microbiology, physical, and biocompatibility testing services to pharmaceutical, medical device, and combination product manufacturers across laboratories in the UK, EU, and US.

Ownership category

akta.pro rank

Product category

Pharmaceutical & Medical Device Testing Services

NAICS

Testing Laboratories and Services (541380), Testing Laboratories and Services (54138), Scientific Research and Development Services (5417)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)

akta.pro secondary industries

Release Testing & Batch Certification (QC) (HLAGADAC), Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK), Environmental Monitoring & Cleanroom Testing (GMP) (HLAGADAL), Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

Keywords

• Pharmaceutical testing services
• Medical device testing
• Contract research organization
• Analytical chemistry testing
• Microbiology laboratory services

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Laboratory Testing Services: Cormica generates revenue primarily through providing contract laboratory testing services to pharmaceutical, medical device, and combination product manufacturers. Services include analytical chemistry testing, microbiology testing, physical and packaging testing, and biocompatibility testing. Revenue is generated through project-based contracts with manufacturers requiring testing for product development, validation, release, and regulatory compliance.
2. Consulting and Regulatory Support: Additional revenue stream from scientific consultancy services including testing strategy development, biological evaluation plans and reports, regulatory submission support, and technical investigations.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Cormica is a contract research organization (CRO) providing GMP, GLP, and ISO 17025 accredited laboratory testing services for pharmaceutical, medical device, and combination product manufacturers. The service portfolio spans analytical chemistry, microbiology, physical and functional testing, packaging testing, and biocompatibility/regulatory support, delivered through accredited laboratories in the UK, EU, and US to support product development, validation, batch release, and global regulatory compliance.

Product overview

Cormica is a global contract research organization (CRO) offering pharmaceutical and medical device testing services through GMP, GLP, and ISO 17025 accredited laboratories in the UK, EU, and US. The company's service portfolio spans analytical chemistry testing, microbiology and sterility testing, physical and functional testing, and biocompatibility and regulatory support. Key testing services include Pre-Filled Syringe Testing, Auto-Injector Testing, Intraocular Lens Testing, Anaesthesia & Respiratory Device Testing, Infusion Set Testing, Cardiovascular Device Testing, On-Body Injector & Wearable Device Testing, Ophthalmic Device Testing, Orthopaedic Device Testing, Dental Device Testing, Robotic Surgery Device Testing, and Inhaler & OINDP Testing. Pharmaceutical testing services include ANDA Services for Generic Pharmaceutical Development, Formulation Development, Solid Form Optimization, Analytical Chemistry Method Development Validation and Transfer, QC Batch Release Testing, ICH Stability Studies, Extractables & Leachables Testing, Impurity Analysis Services, Particle/Powder Properties & Characterisation, and Cleaning Validation & Verification. Microbiology services include Microbiological Quality Control Testing, Sterility Testing, Environmental Monitoring, Bacterial Endotoxin Testing, Bioburden Testing, Antimicrobial Efficacy Testing, and Microbial Identification. The company operates through subsidiaries including Wickham Micro, Medical Engineering Technologies UK, Cormica Bradford, Zwisler Laboratorium, Focus Laboratories, and TPM Labs (US).

Differentiator

Problem solved

Functional benefit

Products and services

• Pre-Filled Syringe Testing Comprehensive testing services for pre-filled syringes evaluating injection forces, dose delivery, packaging integrity, materials safety, and long-term performance aligned with ISO 11040, ISO 11608, USP <1207>, and ISO 11607 standards.
• Auto-Injector Testing Testing services for auto-injectors evaluating activation forces, injection time, dose delivery, and long-term reliability aligned with the ISO 11608 series.
• Intraocular Lens Testing IOL testing services addressing particulate risk, extractables and leachables, sterility assurance, and biological safety aligned with ISO 11979 and global regulatory expectations.
• Anaesthesia & Respiratory Device Testing Testing services for anaesthesia and respiratory devices evaluating particulate contamination, VOC emissions, and device performance aligned with the ISO 18562 series.
• Infusion Set Testing Testing services for infusion sets evaluating flow performance, leakage resistance, and connector compatibility aligned with ISO 8536 and ISO 80369 standards.
• Cardiovascular Device Testing Testing services for cardiovascular devices evaluating fatigue performance, durability, materials safety, and long-term reliability aligned with ISO 25539 and ISO 7198 standards.
• On-Body Injector & Wearable Device Testing Testing services for on-body delivery systems, patch pumps, and connected wearable injectors evaluating adhesion, wear performance, dose delivery, and device reliability.
• ANDA Services for Generic Pharmaceutical Development Analytical solutions supporting the ANDA submission process for generic and complex generic products, including Q1/Q2/Q3 equivalence studies and in vitro bioequivalence studies.
• Solid Form Optimization Early phase API development services including salt and polymorph screening, pre-formulation, and pre-clinical formulation characterization.
• Analytical Chemistry Method Development, Validation and Transfer Method development and validation services aligned with ICH Q14, delivering efficient, accurate, precise and robust analytical methods to GMP standards.
• QC Batch Release Testing GMP batch release testing services covering raw materials, APIs, finished products, combination products, and complex formulations using client, pharmacopoeial, or bespoke methods.
• ICH Stability Studies Storage stability studies aligned with ICH Q1 guidelines covering real-time, accelerated, R&D, degradation, packaging, and shelf life studies.
• Extractables & Leachables Testing Comprehensive extractables and leachables testing for biocompatibility risk assessment of medical devices, drug products, and combination products aligned with ISO 10993-18, USP <1663>/<1664>, and ICH guidelines.
• Impurity Analysis Services Expert impurity analysis services supporting ICH Q3A/B, Q3C, Q3D, ISO 10993, Ph. Eur., and USP requirements with advanced LC-QQQ, GC-QQQ, ICP-MS, XRPD, and Karl Fischer instrumentation.
• Particle / Powder Properties & Characterisation Comprehensive particle and powder characterization using laser diffraction, imaging, and solid-state techniques for understanding particle properties from nanometre to millimetre range.
• Cleaning Validation & Verification Cleaning validation and verification services supporting development and validation of analytical methods for detecting product residues and ensuring equipment cleanliness.
• Microbiological Quality Control Testing Non-sterile microbiological QC testing services including TAMC/TYMC, specified microorganism detection, bioburden testing, and preservative efficacy testing aligned with USP and Ph. Eur.
• Sterility Testing Compendial sterility testing to USP <71>, ISO 11737-2, Ph Eur, and JP requirements with rapid sterility testing options including Celsis Bioluminescence and Scan RDI Chemiluminescence.
• Environmental Monitoring Microbiological environmental monitoring services for GMP facilities including cleanroom monitoring, sampling, EM trending, and microbial identification (MALDI-ToF, MicroSEQ & VITEK).
• Bacterial Endotoxin Testing Bacterial endotoxin testing (LAL testing) using kinetic turbidimetric, kinetic chromogenic, and gel clot methods for detecting endotoxins from gram-negative bacteria.
• Bioburden Testing Bioburden testing services compliant with BS EN ISO 11737-1 for determining viable microbial load on medical devices and pharmaceutical products before sterilization.
• Antimicrobial Efficacy Testing Preservative efficacy and antimicrobial effectiveness testing (AET/PET) aligned with USP <51>, Ph. Eur. 5.1.3, and BP standards.
• Microbial Identification (MALDI-ToF) Microbial identification services using MALDI-ToF, MicroSEQ, and VITEK systems for species-level identification of microorganisms.
• ISO 10993 Biocompatibility Testing Biocompatibility testing services aligned with the ISO 10993 series for medical devices and combination products, supporting biological evaluation requirements.
• Packaging Validation (ISO 11607) Packaging validation services aligned with ISO 11607 covering sterile barrier system evaluation, sealing process validation, and packaging system performance.
• Container Closure Integrity Testing (CCIT) Container closure integrity testing services supporting package integrity verification and USP <1207> expectations for sterile and combination product packaging.

Quantifiable outcome

• Reduce testing turnaround time through rapid sterility testing options
• +1 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered minor.

• AstoriomminorStrategic or Co-development PartnerStrategic partner listed on Cormica's website under 'Our Strategic Partners' - a company providing related scientific/scientific instrumentation services
• Concept Life SciencesminorStrategic or Co-development PartnerStrategic partner listed on Cormica's website under 'Our Strategic Partners' - a company providing analytical and life sciences services

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Eurofins Scientific: Global testing services group providing pharmaceutical, medical device, and microbiological testing with extensive GMP/GLP-accredited laboratory networks — directly comparable to Cormica's broad testing portfolio and multi-country footprint.
• SGS: World-leading testing, inspection and certification company with a Health & Nutrition division offering pharmaceutical and medical device testing — competes with Cormica for similar enterprise customers across regulated testing categories.
• Intertek: Global TIC provider with pharmaceutical and medical device testing services including analytical chemistry, microbiology, and physical/mechanical testing — directly comparable service mix and customer base.
• Charles River Laboratories: Major contract research organization offering pharmaceutical and medical device testing services including biocompatibility, sterility, and analytical services — overlaps significantly with Cormica's combination product testing capabilities.
• TÜV SÜD: Provides medical device testing, ISO 10993 biocompatibility, and pharmaceutical laboratory services with global accreditations — directly comparable to Cormica's medical device testing and regulatory support portfolio.
• WuXi AppTec: Contract research organization offering comprehensive pharmaceutical testing, analytical chemistry, and medical device evaluation services — comparable CRO service breadth with international laboratory footprint.
• Element Materials Testing: Global testing services provider covering medical device mechanical/physical testing, materials characterization, and pharmaceutical-related testing — closely comparable testing service breadth and customer targets.
• Medical Engineering Technologies (MET): UK-based medical device and combination product physical testing specialist — direct domestic peer that is now part of Cormica's subsidiary network, illustrative of the specialized testing niche Cormica operates in.

Broad incumbents

• Labcorp / Covance: Large-scale clinical and bioanalytical laboratory network with central laboratory testing and pharmaceutical development services — relevant broad incumbent in adjacent pharmaceutical testing market segments.

Emerging players

• Pace Analytical Services: US-focused life sciences and environmental testing laboratory with pharma and medical device service lines — relevant emerging player in the North American testing market where Cormica is expanding via TPM Labs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cormica

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cormica